RxDoctor Payments Data

Paiton Calvert

Family · West Des Moines, IANPI 1457986671

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,264 of the $3,667 with a category attached, or 89.0%. It is spread thinly across 18 manufacturers, the largest accounting for just 21.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,253, 4.2 times the $296 reported in 2021. Among family clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,667in general payments, 2019–2025

Across 180 payments — averaging $20.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$805
  • Novartis$485
  • Lilly USA, LLC$362
  • Sun Pharmaceutical Industries Inc.$355
  • UCB, Inc.$311
  • AbbVie$305
  • plus $1K from 12 others

What the payments were for

  • Food & beverage$3,26489%
  • Education$40411%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,667 in reported general payments places this provider in the 95th percentile of 1,268 family providers in Iowa.

See all family providers in Iowa

Medicare billing

Part B allowed, 2024
$51,976
Medicare patients
300
Services billed
1,287

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent SyringeDupilumab26$95,971
Dupixent PenDupilumab12$44,631
Metronidazole17$1,424
Tacrolimus11$1,127
Clobetasol Propionate16$844
Betamethasone Dipropionate13$784
Ketoconazole46$639
Triamcinolone Acetonide30$296
Spironolactone15$277
Hydroxyzine Hcl12$112
Hydrocortisone11$44

Paid to pharmacies, not to this prescriber.

Other family in West Des Moines

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →